Director's Dealings ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number 1985/0002935/06 Share code: APN ISIN: ZAE000066692 ("Aspen" or "the Company") DEALING IN SECURITIES BY DIRECTORS, COMPANY SECRETARY AND DIRECTORS OF A MAJOR SUBSIDIARY In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of the following information: DIRECTORS OF THE COMPANY Director : Stephen Bradley Saad Date of transaction : 1 November 2012 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 15 518 Class of securities : Ordinary shares Grant price : R156.00 Value of Transaction : R2 420 808 Nature of interest : Direct beneficial Clearance obtained : Yes Director : Michael Guy Attridge Date of transaction : 1 November 2012 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 12 829 Class of securities : Ordinary shares Grant price : R156.00 Value of Transaction : R2 001 324 Nature of interest : Direct beneficial Clearance obtained : Yes COMPANY SECRETARY OF THE COMPANY Company Secretary : Riaan Verster Date of transaction : 1 November 2012 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 1 745 Class of securities : Ordinary shares Grant price : R156.00 Value of Transaction : R272 220 Nature of interest : Direct beneficial Clearance obtained : Yes DIRECTORS OF A MAJOR SUBSIDIARY Director : Sean Capazorio Subsidiary Company : Pharmacare Limited Date of transaction : 1 November 2012 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 4 582 Class of securities : Ordinary shares Grant price : R156.00 Value of Transaction : R714 792 Nature of interest : Direct beneficial Clearance obtained : Yes Director : Morne Geyser Subsidiary Company : Pharmacare Limited Date of transaction : 1 November 2012 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 4 391 Class of securities : Ordinary shares Grant price : R156.00 Value of Transaction : R684 996 Nature of interest : Direct beneficial Clearance obtained : Yes Director : Noel Guliwe Subsidiary Company : Pharmacare Limited Date of transaction : 1 November 2012 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 3 894 Class of securities : Ordinary shares Grant price : R156.00 Value of Transaction : R607 464 Nature of interest : Direct beneficial Clearance obtained : Yes All acceptances of deferred bonus shares are deemed to be off-market trades. Durban 2 November 2012 Sponsor Investec Bank Limited Date: 02/11/2012 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.